Search
Feed aggregator
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma 4/12/2024
Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031
Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031 4/12/2024
Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR
Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR 4/12/2024
CryoEM: Evolution and Best Practices
CryoEM: Evolution and Best Practices 4/12/2024
Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This Year
Pfizer Moves Forward With Obesity Pill, Plans Dose Optimization Studies This Year 7/11/2024
Ipsen Inks Potential $1B First-in-Class ADC Deal With Foreseen
Ipsen Inks Potential $1B First-in-Class ADC Deal With Foreseen 7/11/2024
Kazia Offers Secondary OS Data to Build FDA Case for Glioblastoma Drug
Kazia Offers Secondary OS Data to Build FDA Case for Glioblastoma Drug 7/11/2024
FDA Rejects Novo’s Once-Weekly Insulin Injection, Cites Manufacturing Process
FDA Rejects Novo’s Once-Weekly Insulin Injection, Cites Manufacturing Process 7/11/2024
FTC to Sue ‘Big Three’ PBMs for Setting Insulin, Other Drug Prices: WSJ
FTC to Sue ‘Big Three’ PBMs for Setting Insulin, Other Drug Prices: WSJ 7/11/2024
FTC Ban That Would Make Switching Jobs Easier Hits Roadblock
FTC Ban That Would Make Switching Jobs Easier Hits Roadblock 7/11/2024
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Ma...
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Ma... 6/11/2024
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis 6/11/2024
Sage’s Dalzanemdor Shows Effect in Huntington’s Study, Analysts Say Results ‘Underwhelming’
Sage’s Dalzanemdor Shows Effect in Huntington’s Study, Analysts Say Results ‘Underwhelming’ 6/11/2024
Stada Bags European Rights from Alvotech to Biosimilar of Amgen Blockbusters
Stada Bags European Rights from Alvotech to Biosimilar of Amgen Blockbusters 6/11/2024
GSK Appeals Delaware Court’s Decision in Zantac Cases as Plaintiff Drops Lawsuit
GSK Appeals Delaware Court’s Decision in Zantac Cases as Plaintiff Drops Lawsuit 6/11/2024
Lilly Sees More Zepbound Out-of-Pocket Payments as Obesity Pill Nears Phase III Readout
Lilly Sees More Zepbound Out-of-Pocket Payments as Obesity Pill Nears Phase III Readout 6/11/2024
Top 5 Companies Hiring in San Diego
Top 5 Companies Hiring in San Diego 4/11/2024
VC Firm Flagship Raises $3.6B to Create, Support 25 ‘Breakthrough’ Companies
VC Firm Flagship Raises $3.6B to Create, Support 25 ‘Breakthrough’ Companies 7/10/2024
FDA Approves Atopic Dermatitis Label Expansion for Arcutis’ Zoryve Cream
FDA Approves Atopic Dermatitis Label Expansion for Arcutis’ Zoryve Cream 7/10/2024
Amylyx Pivots to GLP-1 Space, Acquires Phase III-Ready Asset from Eiger
Amylyx Pivots to GLP-1 Space, Acquires Phase III-Ready Asset from Eiger 7/10/2024
World Pharma News
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders
- A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy
- Common gout drug may reduce risk of heart attack and stroke
- New nasal vaccine has potential to transform respiratory disease prevention
- MIT research finds particles that enhance mRNA delivery could reduce vaccine dosage and costs